Researchers from the Institute of Science Tokyo have developed CeSPIACE, a peptide inhibitor that blocks SARS-CoV-2 from ...

The lack of available medications in the United States for COVID post-exposure prophylaxis leaves household members in close ...

Scientists have learned more about how SARS-CoV-2 infections, which cause COVID-19, can ruin the ability of immune cells to ...

An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...

A drug called ensitrelvir can help prevent Covid-19 in people who have been exposed within households. This finding comes from an international clinical trial a UVA School of Medicine professor helped ...

The New Normal Five years ago, COVID-19 was declared a global pandemic, marking the official onset of a healthcare crisis ...

Ensitrelvir PEP was safe and effective for COVID-19 prevention among household contacts when administered after the onset of symptoms in an index patient.

The virus that causes COVID-19 continues to mutate. Scientists say that's likely to continue indefinitely, and the virus will ...

Additionally, certain SARS-CoV-2 viral variants may emerge that have substantially reduced ... that circumstances exist justifying the authorization of the emergency use of drugs and biological ...